Table 2.
Diagnosis | Poor General Health |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
18-24 Years Old |
25-29 Years Old |
30-34 Years Old |
35-39 Years Old |
40-44 Years Old |
≥ 45 Years Old |
|||||||
% | Denominator* | % | Denominator* | % | Denominator* | % | Denominator* | % | Denominator* | % | Denominator* | |
Siblings† | 4.8 | 968 | 4.2 | 888 | 5.2 | 1,159 | 7.0 | 1,038 | 6.6 | 754 | 8.3 | 683 |
Survivors | 9.5 | 4,105 | 12.2 | 4,231 | 13.0 | 5,448 | 14.2 | 4,385 | 15.8 | 2,728 | 18.5 | 1,671 |
Leukemia | 8.6 | 1,661 | 11.7 | 1,499 | 12.2 | 1,739 | 12.8 | 1,211 | 14.8 | 542 | 16.7 | 201 |
CNS malignancy | 14.9 | 552 | 15.7 | 581 | 17.8 | 713 | 19.7 | 523 | 24.0 | 295 | 18.7 | 137 |
Hodgkin's lymphoma | 11.1 | 262 | 12.0 | 466 | 12.7 | 810 | 14.3 | 890 | 17.3 | 774 | 21.5 | 667 |
Non-Hodgkin's lymphoma | 5.1 | 317 | 11.4 | 362 | 10.0 | 477 | 14.3 | 430 | 12.8 | 299 | 15.5 | 158 |
Wilms tumor | 8.6 | 455 | 9.3 | 389 | 9.8 | 387 | 13.7 | 208 | 10.9 | 56 | 9.1 | 11 |
Neuroblastoma | 7.9 | 319 | 12.8 | 222 | 9.7 | 239 | 13.4 | 112 | 12.5 | 24 | 0.0 | 3 |
Soft-tissue sarcoma | 9.2 | 316 | 12.2 | 379 | 13.8 | 530 | 11.0 | 450 | 14.4 | 294 | 14.7 | 205 |
Bone malignancy | 10.8 | 223 | 12.2 | 333 | 15.0 | 553 | 14.7 | 561 | 12.4 | 444 | 17.8 | 289 |
Evaluated in cancer survivors only.
These numbers are the denominators for the given percentages.
At the second follow-up questionnaire, only a subset of siblings were asked to complete the questions related to general health, functional impairment, and activity limitations.